Division of Gastroenterology and Hepatology, 982000 University of Nebraska Medical Center, Omaha, Nebraska 68198-2000, USA.
Drugs. 2009;69(13):1739-60. doi: 10.2165/11316390-000000000-00000.
The development of ascites indicates a pathological imbalance between the production and resorption of intraperitoneal fluid. The appearance and composition of ascites are variable, based on the underlying pathophysiology. Most commonly, ascites develops in the setting of decompensated cirrhosis, peritoneal infection, carcinomatosis, congestive heart failure or a combination (mixed ascites). The diagnosis can be difficult in some patients. Management options for ascites from decompensated liver disease focus on low-sodium diets and diuretics supplemented by large-volume paracentesis, transvenous intrahepatic portosystemic shunts and liver transplantation. The development of refractory ascites, hepatic hydrothorax, hyponatraemia or hepatorenal syndrome presents unique challenges to the provider and the patient. In some of these patients, therapy with liver transplantation will be the only viable therapeutic option. The diagnosis of infectious ascites, such as tuberculosis, and carcinomatous ascites remain diagnostic and therapeutic challenges for the clinician.
腹水的形成表明腹腔内液体的产生和吸收之间存在病理性失衡。腹水的出现和成分是可变的,这取决于潜在的病理生理学。最常见的是,在失代偿性肝硬化、腹膜感染、癌性播散、充血性心力衰竭或其组合(混合性腹水)的情况下会发生腹水。在一些患者中,腹水的诊断可能很困难。失代偿性肝病所致腹水的治疗选择侧重于低盐饮食和利尿剂,辅以大量腹腔穿刺抽液、经颈静脉肝内门体分流术和肝移植。难治性腹水、肝性胸水、低钠血症或肝肾综合征的发生给提供者和患者带来了独特的挑战。在这些患者中的一些患者中,肝移植治疗将是唯一可行的治疗选择。感染性腹水(如结核)和癌性腹水的诊断仍然是临床医生面临的诊断和治疗挑战。